Everolimus (EVE) plus exemestane (EXE) in elderly patients (pts) with hormone receptor-positive (HR+), human epidermal growth receptor-2 negative (HER2-) advanced breast cancer (ABC) progressing on prior nonsteroidal aromatase inhibitors (NSAIs) : Insights on safety form BALLET (CRAD001YIC04)

Neven, P.; Generali, D.; Ciruelos, E.M.; Lang, I.; Gavila, J.; Bighin, C.; Borms, M.; Conte, P.; Montemurro, F.; Sartori, D.; Marini, L.; Camozzi, M.; Lorizzo, K.; Ocak, O.; JERUSALEM, Guy

Unpublished conference/Abstract (Scientific congresses and symposiums)

Neven, P.; Generali, D.; Ciruelos, E.M. et al.

2016 • Miami Breast Cancer Conference

Permalink
https://hdl.handle.net/2268/199570

Files (2)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Everolimus (EVE) plus Exemestane (EXE) in elderly patients (pts) with hormone ... - abstract.pdf

Publisher postprint (211.43 kB)

Request a copy

Annexes

Everolimus (EVE) plus Exemestane (EXE) in elderly patients (pts) with hormone ... - poster.pdf

Publisher postprint (317.16 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

oncology

Disciplines :

Oncology

Author, co-author :

Neven, P.

Generali, D.

Ciruelos, E.M.

Lang, I.

Gavila, J.

Bighin, C.

Borms, M.

Conte, P.

Montemurro, F.

Sartori, D.

More authors (5 more)

Language :

English

Title :

Publication date :

2016

Event name :

Miami Breast Cancer Conference

Event place :

Miami, United States

Event date :

March 10-13, 2016

Audience :

International

References of the abstract :

350

Available on ORBi :

since 05 July 2016

Statistics

Number of views

56 (5 by ULiège)

Number of downloads

3 (3 by ULiège)

More statistics